Effectiveness of pneumococcal vaccination in reducing hospitalization and mortality among the elderly: A systematic
Adeeb Bulkhi1, Hadeel A Khadawardi2, Mohammad S Dairi2
1Department of Internal Medicine, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.
Abstract:
This meta-analysis assesses pneumococcal vaccine effectiveness in reducing hospitalization and mortality among the elderly. The studies retrieved from PubMed, Scopus, Embase, and Cochrane through March 2025. Of 3,002 identified studies, 35 met inclusion criteria (30 cohort, 3 RCTs, 2 case-control), encompassing 1.65 million vaccinated and 2.62 million unvaccinated individuals. Pneumonia-related hospitalization significantly declined in subgroups receiving mixed pneumococcal polysaccharide vaccine (PPV) and conjugate vaccine (PCV-13), notably among individuals aged >75 and those with chronic conditions. All-cause hospitalization dropped (OR: 0.94; 95% CI: 0.91-0.97), especially in PPV-23 recipients, Asian populations, and those with comorbidities. Pneumonia mortality decreased across age groups >60, and all-cause mortality declined among those aged 60-75. No significant impact was observed on emergency visit rates. Although findings favor vaccine effectiveness, high heterogeneity warrants further comparative trials to confirm outcomes.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
08:47Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens
Published on: April 5, 2019
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pharmacodynamics in Geriatric Patients: Effects of Age
Drug Dosing: Geriatric Patients
Pneumonia III: Complications and Assessment
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
